<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-11T15:32:23+00:00">
  <iati-activity last-updated-datetime="2026-11-11T13:38:06+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-GTM-T-MSPAS-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Strengthen DOTS Strategy within the Framework of the New Strategy: Stop TB - Guatemala (01-Jul-2016-30-Jun-2019)</narrative>
    </title>
    <description type="1">
      <narrative>Guatemala, Tuberculosis, Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Reduce estimated incidence of TB all forms by 12% in the next three years compared to 2014; Reduce estimated incidence of TB BK+ by 12% in the next three years compared to 2014; Reduce mortality due to tuberculosis by 20% in the next three years compared to 2014. Objectives: Improve the success of treatment of patients with TB and MDR TB with patient-centered support; Reduce the burden of TB in people living with HIV and reduce the burden of HIV in people affected by TB; Strengthen early detection and diagnosis of TB and MDR TB focused on patient care; Strengthen technical program management of the NTP; Strengthen the information and reporting cases of TB system and vital records.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </participating-org>
    <other-identifier ref="GTM-T-MSPASP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2016-07-01" />
    <activity-date type="2" iso-date="2016-07-01" />
    <activity-date type="3" iso-date="2019-06-30" />
    <activity-date type="4" iso-date="2019-06-30" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Serena Buccini</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>serena.buccini@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="GT" percentage="100">
      <narrative>Guatemala</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="100">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="bb065ae5-d9f1-485f-9d78-110f76beaa3f">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-08-29" />
      <value currency="USD" value-date="2016-08-29">452258.78</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c2599e10-a705-492c-934d-415aa0d3c192">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-09-01" />
      <value currency="USD" value-date="2016-09-01">427258.78</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="deae3756-3f8d-44a5-9b93-aa30648fddc3">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-09-01" />
      <value currency="USD" value-date="2016-09-01">10000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="34a55943-1a18-4725-883f-300cf9c7f2c3">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-09-09" />
      <value currency="USD" value-date="2016-09-09">1759328.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="71320cd7-3a71-4358-88c1-cd64bde7c064">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-09-09" />
      <value currency="USD" value-date="2016-09-09">-15000.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="32e163ff-1fbc-442f-8c0b-770a68f1520e">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-09-13" />
      <value currency="USD" value-date="2016-09-13">494068.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="49b5847d-d7cd-4f6d-9aa2-d447d72571d2">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-09-13" />
      <value currency="USD" value-date="2016-09-13">15000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bd3fd16e-160a-4f5f-8130-198905df64d0">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-09-13" />
      <value currency="USD" value-date="2016-09-13">372997.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0f430d06-719e-46df-a922-106b2ff6346f">
      <transaction-type code="7" />
      <transaction-date iso-date="2016-09-21" />
      <value currency="USD" value-date="2016-09-21">408381.13</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="299e194e-ce4f-4b01-a1f7-a1c78512bb29">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-09-30" />
      <value currency="USD" value-date="2016-09-30">-408381.13</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ada82300-f42c-4037-a522-b4935ec6dcbd">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-09-30" />
      <value currency="USD" value-date="2016-09-30">-877263.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fcb2b719-febd-439f-acd0-d178f32bf972">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-09-30" />
      <value currency="USD" value-date="2016-09-30">1773230.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3f2316a9-33de-4064-b38a-57706d055fea">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-10-04" />
      <value currency="USD" value-date="2016-10-04">353862.90</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d8193220-15bb-4e98-9afe-faad85e7c84a">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-12-13" />
      <value currency="USD" value-date="2016-12-13">28520.54</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bf12a38e-4919-4908-ad65-e2910ede5f36">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-02-14" />
      <value currency="USD" value-date="2017-02-14">3708.01</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b63beae3-4cc0-4b5c-b0b9-113da5e92f82">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-06-28" />
      <value currency="USD" value-date="2017-06-28">93359.94</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7b29dfed-de54-4ab7-87cd-a36972bf0fc8">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-21" />
      <value currency="USD" value-date="2017-07-21">150000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cfdd5cc0-8554-4d79-a791-0071fbb20c05">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-21" />
      <value currency="USD" value-date="2017-07-21">2856.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7108689f-4532-4447-91e2-086080c006ee">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-09-26" />
      <value currency="USD" value-date="2017-09-26">89390.72</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="043c9cc2-6787-43fd-b217-034e83f6c35a">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-11-06" />
      <value currency="USD" value-date="2017-11-06">1065840.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f723d127-9986-4d95-9359-7e4d57d32098">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-11-06" />
      <value currency="USD" value-date="2017-11-06">-1051531.89</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2fdd45a9-ea27-4cca-bd8d-139695de1575">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">25000.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="be78c2ad-1f5d-4aa3-a244-64b4ea6192eb">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4f41b5b6-cb1a-4403-bc27-fd0e89287f35">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-01-23" />
      <value currency="USD" value-date="2018-01-23">241782.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6e981cea-f941-4427-8fe0-4dbd47aad22c">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-03-22" />
      <value currency="USD" value-date="2018-03-22">25000.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c1749bf6-0696-4d33-94be-c16b5bccc57c">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-03-27" />
      <value currency="USD" value-date="2018-03-27">75276.44</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="212e8703-1cc6-447c-8c01-3718f825c63f">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-04-03" />
      <value currency="USD" value-date="2018-04-03">8872.39</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ccf9b7b0-d165-481d-97f8-b8bd0a866b0a">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-05-04" />
      <value currency="USD" value-date="2018-05-04">79829.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="69af57f0-f45d-47dc-92b3-c43c62a01938">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-08-07" />
      <value currency="USD" value-date="2018-08-07">106027.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5ed704ca-314c-4ced-a5b8-835d3193349e">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-08-14" />
      <value currency="USD" value-date="2018-08-14">4376.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a60306fa-f849-4afa-92f9-fbd78acb38f0">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-08-14" />
      <value currency="USD" value-date="2018-08-14">101809.95</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6668eb66-22e0-49a7-9744-6415a368b4fe">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-09" />
      <value currency="USD" value-date="2018-10-09">248679.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7ab6dfa7-783f-40c4-b66e-db3e3c95a6d8">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-19" />
      <value currency="USD" value-date="2018-10-19">51447.55</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8637e603-e727-4856-821e-995938aa4efb">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-19" />
      <value currency="USD" value-date="2018-10-19">17693.44</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="afcd979a-8866-490a-b3d5-b10f802668d3">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-10-31" />
      <value currency="USD" value-date="2018-10-31">-130047.23</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c9fe52e5-1275-44ab-bd77-de57ad627d23">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-10-31" />
      <value currency="USD" value-date="2018-10-31">788221.59</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c7495eea-1ee9-4d77-9f55-f1abcc02d85e">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-11-02" />
      <value currency="USD" value-date="2018-11-02">238577.36</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e42a0589-64a1-43cd-ad72-3dbcfafa5d8f">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-11-02" />
      <value currency="USD" value-date="2018-11-02">41704.17</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="efdb1ad5-7f89-467c-8055-7e7ad8d8af25">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-11-02" />
      <value currency="USD" value-date="2018-11-02">172356.06</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f8bf2ddd-fdae-456d-b5e0-817efd9ef662">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-11-13" />
      <value currency="USD" value-date="2018-11-13">335220.82</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="183be491-f270-4b6c-a50b-4802a332e195">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-12-18" />
      <value currency="USD" value-date="2018-12-18">-363.18</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c603e135-5dfb-45e0-ba87-6c36de168657">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-12-18" />
      <value currency="USD" value-date="2018-12-18">1547500.66</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="35ad9d22-35ba-42f3-8a13-53ceccd1cba9">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-19" />
      <value currency="USD" value-date="2018-12-19">612769.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5a576f43-1160-4be8-b177-c8647b711bb2">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-19" />
      <value currency="USD" value-date="2018-12-19">322264.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2d4e3036-8b09-4c82-a253-8523828cf067">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-12-31">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="25ac08e9-870c-43f7-b088-ff12f7c8095e">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-01-22" />
      <value currency="USD" value-date="2019-01-22">4696.21</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4b7ab1ed-0c4d-4d39-ab03-e8283e10651a">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-02-01" />
      <value currency="USD" value-date="2019-02-01">20000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0adb1a5e-0ccd-4245-9ba1-5c99989a141f">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-03-28" />
      <value currency="USD" value-date="2019-03-28">17128.56</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7ba788fe-5e4e-45ad-bdf8-cd5962781d9d">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-03-28" />
      <value currency="USD" value-date="2019-03-28">4028.88</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="939ba3d5-e691-4438-9f22-7eadbd70e779">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-03-28" />
      <value currency="USD" value-date="2019-03-28">78109.80</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b7531bd7-379f-4c59-8df8-559601d35b4a">
      <transaction-type code="7" />
      <transaction-date iso-date="2020-01-10" />
      <value currency="USD" value-date="2020-01-10">20000.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1be7fa0e-a027-4f41-8e04-c2d0616651da">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-01-20" />
      <value currency="USD" value-date="2020-01-20">-20000.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0e58b963-74fa-4bc3-ac68-d287ed212133">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-07-01" />
      <value currency="USD" value-date="2020-07-01">-488504.21</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="464c82f7-9fa2-4fa0-961a-bd6af28bc8f5">
      <transaction-type code="7" />
      <transaction-date iso-date="2020-07-06" />
      <value currency="USD" value-date="2020-07-06">1740.56</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="efc2b8e8-c799-4f2f-a231-bd52f807962d">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-07-10" />
      <value currency="USD" value-date="2020-07-10">-1740.56</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6cf6b1c6-71bc-4457-9979-0daf40939967">
      <transaction-type code="7" />
      <transaction-date iso-date="2020-08-07" />
      <value currency="USD" value-date="2020-08-07">86350.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="98d44c4b-037a-4bda-8dce-f3fe5ff4dd48">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-08-12" />
      <value currency="USD" value-date="2020-08-12">-86350.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/GTM-T-MSPAS" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 40.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 68; Denominator: 172; Percentage: 39.5%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 34; Denominator: 185; Percentage: 18.4%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 42; Denominator: 185; Percentage: 22.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 79; Denominator: 185; Percentage: 42.7%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 75; Denominator: 185; Percentage: 40.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 46.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 26.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 105.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 57.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 59.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 50.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 42.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 60; Denominator: 68; Percentage: 88.2%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 30; Denominator: 79; Percentage: 38%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 37; Denominator: 42; Percentage: 88.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 70; Denominator: 79; Percentage: 88.6%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 62; Denominator: 75; Percentage: 82.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 41.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 23.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 94.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 38.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 53.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 36.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" ascending="0" aggregation-status="0">
        <title>
          <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31" value="17.9">
          <comment>
            <narrative>Numerator: 7; Denominator: 39.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="16.7">
            <comment>
              <narrative>Numerator: 10; Denominator: 60.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="16.7">
            <comment>
              <narrative>Numerator: 5; Denominator: 30.</narrative>
            </comment>
          </target>
          <actual value="10">
            <comment>
              <narrative>Numerator: 3; Denominator: 30.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="15">
            <comment>
              <narrative>Numerator: 6; Denominator: 40.</narrative>
            </comment>
          </target>
          <actual value="3.2">
            <comment>
              <narrative>Numerator: 2; Denominator: 62.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="14.6">
            <comment>
              <narrative>Numerator: 6; Denominator: 41.</narrative>
            </comment>
          </target>
          <actual value="8.7">
            <comment>
              <narrative>Numerator: 2; Denominator: 23.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="11.3">
            <comment>
              <narrative>Numerator: 6; Denominator: 53.</narrative>
            </comment>
          </target>
          <actual value="5.3">
            <comment>
              <narrative>Numerator: 2; Denominator: 38.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="11.3">
            <comment>
              <narrative>Numerator: 6; Denominator: 53.</narrative>
            </comment>
          </target>
          <actual value="8.3">
            <comment>
              <narrative>Numerator: 3; Denominator: 36.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="16.3">
          <comment>
            <narrative>Numerator: 38; Denominator: 233.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="35.1">
            <comment>
              <narrative>Numerator: 94; Denominator: 268.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="16.4">
            <comment>
              <narrative>Numerator: 47; Denominator: 287.</narrative>
            </comment>
          </target>
          <actual value="9.1">
            <comment>
              <narrative>Numerator: 26; Denominator: 287.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="45.6">
            <comment>
              <narrative>Numerator: 131; Denominator: 287.</narrative>
            </comment>
          </target>
          <actual value="43.6">
            <comment>
              <narrative>Numerator: 75; Denominator: 172.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="25.8">
            <comment>
              <narrative>Numerator: 84; Denominator: 326.</narrative>
            </comment>
          </target>
          <actual value="65.2">
            <comment>
              <narrative>Numerator: 73; Denominator: 112.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="63.5">
            <comment>
              <narrative>Numerator: 207; Denominator: 326.</narrative>
            </comment>
          </target>
          <actual value="65.3">
            <comment>
              <narrative>Numerator: 130; Denominator: 199.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="37.6">
            <comment>
              <narrative>Numerator: 131; Denominator: 348.</narrative>
            </comment>
          </target>
          <actual value="28.9">
            <comment>
              <narrative>Numerator: 77; Denominator: 266.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among key affected populations/high risk groups</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among key affected populations/high risk groups</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 97.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 180; Denominator: 18058; Percentage: 1%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 90; Denominator: 18058; Percentage: 0.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 84; Denominator: 22680; Percentage: 0.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 190; Denominator: 18058; Percentage: 1.1%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 163; Denominator: 23016; Percentage: 0.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 100.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 100.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 250.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 210.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 150.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 110.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of children &lt;5 in contact with TB patients who began isonizide preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of children &lt;5 in contact with TB patients who began isonizide preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 843.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1814; Denominator: 8246; Percentage: 22%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 907; Denominator: 9217; Percentage: 9.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 357; Denominator: 9217; Percentage: 3.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2537; Denominator: 9217; Percentage: 27.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 868; Denominator: 9217; Percentage: 9.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2340.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 523.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4681.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 985.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1436.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 500.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 3224.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4230; Denominator: 9400; Percentage: 45%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2115; Denominator: 9450; Percentage: 22.4%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1564; Denominator: 9450; Percentage: 16.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4727; Denominator: 9450; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3311; Denominator: 9450; Percentage: 35%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1750.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1869; Percentage: 107%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3500.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3526.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1784.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1888.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 2094.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2748; Denominator: 6110; Percentage: 45%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1375; Denominator: 6142; Percentage: 22.4%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1194; Denominator: 6142; Percentage: 19.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3073; Denominator: 6142; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2721; Denominator: 6142; Percentage: 44.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1469.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1393.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2700.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2635.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1391.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1495.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="86.6">
          <comment>
            <narrative>Numerator: 1813; Denominator: 2093.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="87" />
          <actual value="86.9">
            <comment>
              <narrative>Numerator: 1958; Denominator: 2254.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="89">
            <comment>
              <narrative>Numerator: 2403; Denominator: 2700.</narrative>
            </comment>
          </target>
          <actual value="86.7">
            <comment>
              <narrative>Numerator: 1985; Denominator: 2290.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="89">
            <comment>
              <narrative>Numerator: 2475; Denominator: 2782.</narrative>
            </comment>
          </target>
          <actual value="86.8">
            <comment>
              <narrative>Numerator: 2201; Denominator: 2536.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="69.1">
          <comment>
            <narrative>Numerator: 199; Denominator: 288.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="79.9">
            <comment>
              <narrative>Numerator: 230; Denominator: 288.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="84.7">
            <comment>
              <narrative>Numerator: 244; Denominator: 288.</narrative>
            </comment>
          </target>
          <actual value="67.7">
            <comment>
              <narrative>Numerator: 193; Denominator: 285.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="94.8">
            <comment>
              <narrative>Numerator: 273; Denominator: 288.</narrative>
            </comment>
          </target>
          <actual value="86.9">
            <comment>
              <narrative>Numerator: 252; Denominator: 290.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="85.6">
          <comment>
            <narrative>Numerator: 2766; Denominator: 3231.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="86" />
          <actual value="87.5">
            <comment>
              <narrative>Numerator: 2809; Denominator: 3210.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="88">
            <comment>
              <narrative>Numerator: 3080; Denominator: 3500.</narrative>
            </comment>
          </target>
          <actual value="87.3">
            <comment>
              <narrative>Numerator: 2684; Denominator: 3076.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="89">
            <comment>
              <narrative>Numerator: 3175; Denominator: 3567.</narrative>
            </comment>
          </target>
          <actual value="87.4">
            <comment>
              <narrative>Numerator: 2704; Denominator: 3094.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="92.7">
          <comment>
            <narrative>Numerator: 228; Denominator: 246.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="93.3">
            <comment>
              <narrative>Numerator: 250; Denominator: 268.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="45">
            <comment>
              <narrative>Numerator: 126; Denominator: 280.</narrative>
            </comment>
          </target>
          <actual value="22.1">
            <comment>
              <narrative>Numerator: 62; Denominator: 280.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="94.3">
            <comment>
              <narrative>Numerator: 264; Denominator: 280.</narrative>
            </comment>
          </target>
          <actual value="54.1">
            <comment>
              <narrative>Numerator: 131; Denominator: 242.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="45.6">
            <comment>
              <narrative>Numerator: 139; Denominator: 305.</narrative>
            </comment>
          </target>
          <actual value="0">
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="95.4">
            <comment>
              <narrative>Numerator: 291; Denominator: 305.</narrative>
            </comment>
          </target>
          <actual value="78">
            <comment>
              <narrative>Numerator: 206; Denominator: 264.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="48.1">
            <comment>
              <narrative>Numerator: 153; Denominator: 318.</narrative>
            </comment>
          </target>
          <actual value="40.4">
            <comment>
              <narrative>Numerator: 203; Denominator: 502.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="30">
          <comment>
            <narrative>Numerator: 2790; Denominator: 9300.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="88">
            <comment>
              <narrative>Numerator: 3722; Denominator: 4230.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="39.4">
            <comment>
              <narrative>Numerator: 1861; Denominator: 4727.</narrative>
            </comment>
          </target>
          <actual value="94">
            <comment>
              <narrative>Numerator: 1470; Denominator: 1564.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="89.1">
            <comment>
              <narrative>Numerator: 4211; Denominator: 4727.</narrative>
            </comment>
          </target>
          <actual value="96">
            <comment>
              <narrative>Numerator: 3178; Denominator: 3311.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="46.5">
            <comment>
              <narrative>Numerator: 1628; Denominator: 3500.</narrative>
            </comment>
          </target>
          <actual value="99.5">
            <comment>
              <narrative>Numerator: 1859; Denominator: 1869.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="93">
            <comment>
              <narrative>Numerator: 3255; Denominator: 3500.</narrative>
            </comment>
          </target>
          <actual value="99.3">
            <comment>
              <narrative>Numerator: 3502; Denominator: 3526.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="47">
            <comment>
              <narrative>Numerator: 1676.49; Denominator: 3567.</narrative>
            </comment>
          </target>
          <actual value="48.5">
            <comment>
              <narrative>Numerator: 1832; Denominator: 3776.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new HIV-positive patients starting IPT during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new HIV-positive patients starting IPT during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="13.2">
          <comment>
            <narrative>Numerator: 316; Denominator: 2385.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="21.2">
            <comment>
              <narrative>Numerator: 720; Denominator: 3400.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="14.7">
            <comment>
              <narrative>Numerator: 360; Denominator: 2450.</narrative>
            </comment>
          </target>
          <actual value="34.2">
            <comment>
              <narrative>Numerator: 839; Denominator: 2450.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="35.1">
            <comment>
              <narrative>Numerator: 860; Denominator: 2450.</narrative>
            </comment>
          </target>
          <actual value="24.6">
            <comment>
              <narrative>Numerator: 860; Denominator: 3501.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="19.6">
            <comment>
              <narrative>Numerator: 500; Denominator: 2550.</narrative>
            </comment>
          </target>
          <actual value="12.7">
            <comment>
              <narrative>Numerator: 203; Denominator: 1598.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="45.1">
            <comment>
              <narrative>Numerator: 1150; Denominator: 2550.</narrative>
            </comment>
          </target>
          <actual value="17.5">
            <comment>
              <narrative>Numerator: 350; Denominator: 2005.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="25">
            <comment>
              <narrative>Numerator: 650; Denominator: 2600.</narrative>
            </comment>
          </target>
          <actual value="8">
            <comment>
              <narrative>Numerator: 223; Denominator: 2780.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-11T13:38:06+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-GTM-T-MSPAS-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Strengthen DOTS Strategy within the Framework of the New Strategy: Stop TB - Guatemala (01-Jul-2019-30-Jun-2022)</narrative>
    </title>
    <description type="1">
      <narrative>Guatemala, Tuberculosis, Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To reduce the prevalence, incidence, mortality and human suffering due to tuberculosis in the country, strengthening comprehensive and integrated care services for promotion, prevention and care, with a person, family and community centered approach. Objectives: Strengthen early detection, diagnosis and treatment of drug-sensitive TB, especially in high-risk groups; Strengthen early detection, diagnosis and treatment of DR-TB, especially in high-risk groups; Reduce the burden of TB for PLHIV and HIV on people affected by TB; Strengthen the commitment of communities, civil society organizations and all public and private health care providers; Strengthen the system for information and notification of cases of TB and vital records (mortality due to TB).</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </participating-org>
    <other-identifier ref="GTM-T-MSPASP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2019-07-01" />
    <activity-date type="2" iso-date="2019-07-01" />
    <activity-date type="3" iso-date="2022-06-30" />
    <activity-date type="4" iso-date="2022-06-30" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Serena Buccini</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>serena.buccini@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="GT" percentage="100">
      <narrative>Guatemala</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="67.45">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="32.55">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="955f4722-71fb-4b46-8bd2-2d741fdad76b" percentage="0.06">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="12.25">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="2e778829-d9f6-4382-b52a-31c55a719622" percentage="9.54">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Other program management intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="79f56a06-e483-471f-ad35-812bf3014339" percentage="0.73">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Administrative and finance data sources</narrative>
        </description>
      </budget-item>
      <budget-item code="c9a33ca8-7a81-4232-9a19-1315956af36c" percentage="0.29">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="043741b4-bd0a-492c-8759-b4cac0a50e64" percentage="0.04">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Other health information systems and M&amp;E intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="004842a6-d6eb-49a2-a763-882fd356689a" percentage="0.2">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="5221e091-6641-4eee-b68d-9b5879a96a78" percentage="2.45">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="41f514b1-2e70-4f77-98c1-68e6052dc6a9" percentage="1.61">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="ad843466-bf87-44ef-9b83-217a8cfb22d0" percentage="5.39">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; National costed supply chain master plan, and implementation</narrative>
        </description>
      </budget-item>
      <budget-item code="1c7b99cb-f18c-499f-a55d-f7a0d6b99b21" percentage="14.45">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a4cf383e-48f0-4449-bdfd-4fefcc86f8e3" percentage="0.78">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Community MDR-TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="8bfd5db3-426b-4dc3-aec1-929f85b850a4" percentage="1.88">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Other MDR-TB intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="3637a37c-6acc-4a5b-b7e4-00640fd7e2ec" percentage="0.72">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="f7014493-22e9-4c03-96d0-144fbb3a254f" percentage="30.77">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="e6d6284e-9e23-498f-91ee-4393f4aa49a1" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Collaborative activities with other programs and sectors (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="a0ec8795-341f-4d7b-9bdd-618cfc782127" percentage="0.61">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="cbff055b-fbc0-468b-9604-e69b10cbd9dd" percentage="0.61">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="1a563d22-2c21-4f9a-b142-805695850ac9" percentage="1.91">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="56afe3f2-1fa3-4fd3-b845-9ea07f4bfd51" percentage="10.62">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="accfbf9b-023f-4bd8-b952-bf1cb13e8e9b" percentage="1.54">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="0da342b5-b462-4465-bf9a-1fdb9d39596f" percentage="1.37">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Removing human rights and gender related barriers to TB care and prevention</narrative>
        </description>
      </budget-item>
      <budget-item code="edbef7da-ca99-4741-8ce0-ea3ba6cd3d3b" percentage="1.25">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="92e11022-488c-4948-abb3-b61f3d9ca4f6" percentage="0.92">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">682442.69</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">1879953.70</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">2018990.04</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">1268096.08</value>
    </budget>
    <capital-spend percentage="40.72" />
    <transaction ref="05f6ef3e-2022-487b-a2ce-682292b373f3">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-07-12" />
      <value currency="USD" value-date="2019-07-12">3663724.42</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7180ce6d-5da0-461d-93ea-0fa1ede7754d">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-07-16" />
      <value currency="USD" value-date="2019-07-16">199690.42</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4ac3fa46-18f4-4e95-aa30-f123f088de5d">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-08-07" />
      <value currency="USD" value-date="2019-08-07">25000.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="85a00344-e4fe-493f-b10e-e458fbed0997">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-10-11" />
      <value currency="USD" value-date="2019-10-11">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="489c6424-eb4f-48f8-9d4d-f753192b6434">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-10-22" />
      <value currency="USD" value-date="2019-10-22">102987.94</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0de546b0-86e4-403d-83ad-ee484bcfc0d3">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-11-19" />
      <value currency="USD" value-date="2019-11-19">130989.19</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="808cc4c6-c2a4-4b6f-b073-c826ae292796">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-01-30" />
      <value currency="USD" value-date="2020-01-30">146212.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="424e0298-e907-44fe-98c5-0b42a2e689f1">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-13" />
      <value currency="USD" value-date="2020-02-13">124840.07</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0142a9e0-c89a-4e4a-bbdc-5b1f35c19ce4">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-03-12" />
      <value currency="USD" value-date="2020-03-12">15285.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="549b7727-8862-47d7-a042-05d0e71598ea">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-03-12" />
      <value currency="USD" value-date="2020-03-12">20000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e5f3cef4-40ea-443b-8b5a-d408f52b7390">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-03-12" />
      <value currency="USD" value-date="2020-03-12">25774.37</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cb731c96-dab2-422d-bb18-73d8f4f13d9d">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-04-23" />
      <value currency="USD" value-date="2020-04-23">306946.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="85d42c69-6ddc-4b31-9c4b-d2cc9365f306">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-08" />
      <value currency="USD" value-date="2020-05-08">25000.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0a19a0b8-2e75-4968-9fee-d03d98fc147f">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-05-13" />
      <value currency="USD" value-date="2020-05-13">32070.67</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="050fe890-13d4-4882-8543-cd7b0987b3a7">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-08-12" />
      <value currency="USD" value-date="2020-08-12">1209367.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cbb4e74d-5bb4-4ac1-9d92-627412d22166">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-08-26" />
      <value currency="USD" value-date="2020-08-26">51894.04</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3caf901e-8c28-4b93-ac2e-122d279d5aef">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-03" />
      <value currency="USD" value-date="2020-12-03">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ad12681a-5787-4782-b397-eea2efb28812">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-09" />
      <value currency="USD" value-date="2020-12-09">15465.73</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1b74e499-00bd-4585-bfe8-7640747a512b">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-12-17" />
      <value currency="USD" value-date="2020-12-17">-1282201.99</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="af6bb425-b8dc-4b98-9bdd-63070bdd3808">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-12-17" />
      <value currency="USD" value-date="2020-12-17">1812465.85</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7c7b8c09-7957-474f-91c8-296d931f28c6">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-01-20" />
      <value currency="USD" value-date="2021-01-20">12700.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c0c4b8c1-8a1e-4bfe-912c-a20ef6c31cc5">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-01-28" />
      <value currency="USD" value-date="2021-01-28">142722.76</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a6dc5dad-dfc3-47f7-9ba2-cb2f56724e80">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-03-12" />
      <value currency="USD" value-date="2021-03-12">19875.44</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7d0c38f0-ae03-41a8-9860-ad9a8e4dac42">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-01" />
      <value currency="USD" value-date="2021-07-01">31635.96</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0e46ff82-0233-452e-b5d4-22fcf63b36a4">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-07" />
      <value currency="USD" value-date="2021-07-07">25000.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ac1f0ef4-d1ba-4c43-9b3b-02904451d4a7">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-15" />
      <value currency="USD" value-date="2021-07-15">6101.68</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="600e54f2-db51-41e0-8265-7a8fc6ce0470">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-02" />
      <value currency="USD" value-date="2021-09-02">12700.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bd980e9d-a828-4570-95ba-ecd0147f4ae8">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-08" />
      <value currency="USD" value-date="2021-09-08">67833.60</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2e065367-9bc1-49ec-9a36-818c58504dfb">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-10-01" />
      <value currency="USD" value-date="2021-10-01">18451.37</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5a3602bb-b8cc-47dc-a50f-7476cc5aecf3">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-13" />
      <value currency="USD" value-date="2021-10-13">-18451.37</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="345566bc-38d8-47c5-b573-dd777eb5491f">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-21" />
      <value currency="USD" value-date="2021-10-21">119658.66</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="682b84df-61dd-4aa7-86f4-00c88ea4fcbe">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-01" />
      <value currency="USD" value-date="2021-11-01">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="dc94ea92-8a59-4ba0-b69b-43ebf7aa30e9">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-11-02" />
      <value currency="USD" value-date="2021-11-02">1565496.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f0480923-c4a0-48ae-aea0-8d54a06ea6f4">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-11-02" />
      <value currency="USD" value-date="2021-11-02">-1399237.75</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="25315ac5-a7d7-4170-a22b-67582fb06fdb">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-04" />
      <value currency="USD" value-date="2021-11-04">18961.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a8ae556d-3388-4ae1-8e53-15a36afdf3fc">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-04" />
      <value currency="USD" value-date="2021-11-04">48127.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e86add85-caba-490d-95a2-d5db6f71c3c4">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-04" />
      <value currency="USD" value-date="2021-11-04">549497.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d4b03be5-68a8-43a4-bb8a-85db5922fbff">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-18" />
      <value currency="USD" value-date="2021-11-18">24315.10</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4746579c-c64d-4f42-a681-9847358c3243">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-01-27" />
      <value currency="USD" value-date="2022-01-27">38220.63</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8c354e2d-4b68-491a-968d-59cdf31730aa">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-02-03" />
      <value currency="USD" value-date="2022-02-03">496170.26</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c798e8a4-8820-4ee0-ae9e-db1e12af5a27">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-02-03" />
      <value currency="USD" value-date="2022-02-03">46437.37</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e7216933-9e92-42cc-9449-4dac868feba3">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-02-03" />
      <value currency="USD" value-date="2022-02-03">79118.16</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="32d944a9-900c-4ab8-92b9-2d015be17ae8">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-02-25" />
      <value currency="USD" value-date="2022-02-25">25000.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f5bd3145-ac3d-4842-90af-d7033cc04dd2">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-24" />
      <value currency="USD" value-date="2022-03-24">168586.31</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cc578909-f179-4cba-826a-165e6ebce1fd">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-04-04" />
      <value currency="USD" value-date="2022-04-04">3971.05</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d9b8d159-a80b-4987-a16a-1f3c3a706326">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-04-08" />
      <value currency="USD" value-date="2022-04-08">-3971.05</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b33f5477-da2e-4a77-bb8f-a2bf3711525b">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-04-28" />
      <value currency="USD" value-date="2022-04-28">9325.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="43604e81-0a44-482e-bc7b-04cac20f1c7b">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-05-17" />
      <value currency="USD" value-date="2022-05-17">367404.82</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8ac5e31c-60e4-44d2-b42c-ffdc5190d8d7">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-05-17" />
      <value currency="USD" value-date="2022-05-17">-86738.17</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="644fa30a-886a-419a-a51b-497d1ad11898">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">62755.87</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bcc5d04e-5fad-465a-81e0-af10673cc57e">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">246593.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d995d26a-dd3e-449f-bffd-c925dd10ee1b">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">58055.95</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0b7e59f9-85ea-4790-8fa6-e9ce35c1765a">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-06-01" />
      <value currency="USD" value-date="2022-06-01">5031.24</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4b5a6eb0-b141-4807-b55e-182e20491efb">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-02" />
      <value currency="USD" value-date="2022-06-02">-5031.24</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="151b40aa-d072-4c8d-8163-6bf17c3f841a">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-16" />
      <value currency="USD" value-date="2022-06-16">279139.92</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1da388fa-7e69-4af5-8a60-c3bf3c448251">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-06-23" />
      <value currency="USD" value-date="2022-06-23">279139.92</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2a24aa13-4d47-4727-8b93-7f9202fbe90d">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-10-01" />
      <value currency="USD" value-date="2022-10-01">6002.26</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bc432f3a-2074-403a-baf3-7350a339a618">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-19" />
      <value currency="USD" value-date="2022-10-19">-6002.26</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d7091ec6-2567-4b45-9b7e-4a0f8215c24a">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-12-01" />
      <value currency="USD" value-date="2022-12-01">23470.38</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="17d82c6b-f0e5-484e-b1ee-ac0636ed5029">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-12-15" />
      <value currency="USD" value-date="2022-12-15">-23470.38</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="48d29d01-8dd1-4e4a-aa56-5967b5f7dfae">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-23" />
      <value currency="USD" value-date="2023-02-23">-25000.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="GTM-T-MSPASP02-EXP-20200630">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-06-30" />
      <value currency="USD" value-date="2020-06-30">605631.95</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health and Social Assistance of the Republic of Guatemala for GTM-T-MSPASP02, Jul 2019 to Jun 2020.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
    </transaction>
    <transaction ref="GTM-T-MSPASP02-EXP-20210630">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-06-30" />
      <value currency="USD" value-date="2021-06-30">1593550.70</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health and Social Assistance of the Republic of Guatemala for GTM-T-MSPASP02, Jul 2020 to Jun 2021.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
    </transaction>
    <transaction ref="GTM-T-MSPASP02-EXP-20220630">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-06-30" />
      <value currency="USD" value-date="2022-06-30">2346981.59</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health and Social Assistance of the Republic of Guatemala for GTM-T-MSPASP02, Jul 2021 to Jun 2022.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
    </transaction>
    <transaction ref="GTM-T-MSPASP02-EXP-20221230">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-12-30" />
      <value currency="USD" value-date="2022-12-30">290188.29</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health and Social Assistance of the Republic of Guatemala for GTM-T-MSPASP02, Jul 2022 to Dec 2022.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/GTM-T-MSPAS" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 75.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1; Denominator: 75; Percentage: 1.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1; Denominator: 75; Percentage: 1.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1; Denominator: 75; Percentage: 1.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1; Denominator: 75; Percentage: 1.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1; Denominator: 75; Percentage: 1.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1; Denominator: 75; Percentage: 1.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 74; Denominator: 75; Percentage: 98.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 74; Denominator: 75; Percentage: 98.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 74; Denominator: 75; Percentage: 98.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 74; Denominator: 75; Percentage: 98.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 74; Denominator: 75; Percentage: 98.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 74; Denominator: 75; Percentage: 98.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 41; Denominator: 75; Percentage: 54.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 41; Denominator: 75; Percentage: 54.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 41; Denominator: 75; Percentage: 54.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 41; Denominator: 75; Percentage: 54.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 41; Denominator: 75; Percentage: 54.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 41; Denominator: 75; Percentage: 54.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 34; Denominator: 75; Percentage: 45.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 34; Denominator: 75; Percentage: 45.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 34; Denominator: 75; Percentage: 45.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 34; Denominator: 75; Percentage: 45.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 34; Denominator: 75; Percentage: 45.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 34; Denominator: 75; Percentage: 45.33%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 40.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 53.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 51; Denominator: 53; Percentage: 96.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1; Denominator: 53; Percentage: 1.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 17; Denominator: 53; Percentage: 32.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 35; Denominator: 53; Percentage: 66%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 40.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 38.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 37; Denominator: 38; Percentage: 97.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1; Denominator: 38; Percentage: 2.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 11; Denominator: 38; Percentage: 28.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 27; Denominator: 38; Percentage: 71.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 40.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 41.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 40; Denominator: 41; Percentage: 97.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 41; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 17; Denominator: 41; Percentage: 41.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 24; Denominator: 41; Percentage: 58.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 42.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 33.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 29; Denominator: 33; Percentage: 87.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 2; Denominator: 33; Percentage: 6.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 16; Denominator: 33; Percentage: 48.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 17; Denominator: 33; Percentage: 51.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 88.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 73.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 43.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 33.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 31; Denominator: 33; Percentage: 93.94%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 2; Denominator: 33; Percentage: 6.06%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 11; Denominator: 33; Percentage: 33.33%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 22; Denominator: 33; Percentage: 66.67%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 45.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 40.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 39; Denominator: 40; Percentage: 97.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1; Denominator: 40; Percentage: 2.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 14; Denominator: 40; Percentage: 35%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 26; Denominator: 40; Percentage: 65%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 62.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 62; Denominator: 62; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 62; Denominator: 62; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 62; Denominator: 62; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 62; Denominator: 62; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 62; Denominator: 62; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 62; Denominator: 62; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 62; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 62; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 62; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 62; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 62; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 62; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 25; Denominator: 62; Percentage: 40.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 25; Denominator: 62; Percentage: 40.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 25; Denominator: 62; Percentage: 40.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 25; Denominator: 62; Percentage: 40.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 25; Denominator: 62; Percentage: 40.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 25; Denominator: 62; Percentage: 40.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 37; Denominator: 62; Percentage: 108.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 37; Denominator: 62; Percentage: 108.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 37; Denominator: 62; Percentage: 108.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 37; Denominator: 62; Percentage: 108.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 37; Denominator: 62; Percentage: 108.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 37; Denominator: 62; Percentage: 108.06%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 40.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 43.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 42; Denominator: 43; Percentage: 97.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1; Denominator: 43; Percentage: 2.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 14; Denominator: 43; Percentage: 32.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 29; Denominator: 43; Percentage: 67.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 40.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 26.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 25; Denominator: 26; Percentage: 96.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1; Denominator: 26; Percentage: 3.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 9; Denominator: 26; Percentage: 34.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 17; Denominator: 26; Percentage: 65.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 40.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 34.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 34; Denominator: 34; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 34; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 14; Denominator: 34; Percentage: 41.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 20; Denominator: 34; Percentage: 58.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 42.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 21.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 19; Denominator: 21; Percentage: 90.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 2; Denominator: 21; Percentage: 9.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 11; Denominator: 21; Percentage: 52.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 10; Denominator: 21; Percentage: 47.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 43.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 30.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 28; Denominator: 30; Percentage: 93.33%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 2; Denominator: 30; Percentage: 6.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 10; Denominator: 30; Percentage: 33.33%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 20; Denominator: 30; Percentage: 66.67%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 88.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 62.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 45.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 32.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 31; Denominator: 32; Percentage: 96.88%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1; Denominator: 32; Percentage: 3.12%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 12; Denominator: 32; Percentage: 37.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 20; Denominator: 32; Percentage: 62.5%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="30.07">
          <comment>
            <narrative>Numerator: 1036; Denominator: 3445.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="35">
            <comment>
              <narrative>Numerator: 624; Denominator: 1783.</narrative>
            </comment>
          </target>
          <actual value="61">
            <comment>
              <narrative>Numerator: 1075; Denominator: 1763.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="40.01">
            <comment>
              <narrative>Numerator: 743; Denominator: 1857.</narrative>
            </comment>
          </target>
          <actual value="66.2">
            <comment>
              <narrative>Numerator: 959; Denominator: 1449.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 2229; Denominator: 3715.</narrative>
            </comment>
          </target>
          <actual value="64">
            <comment>
              <narrative>Numerator: 1745; Denominator: 2725.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="64.97">
            <comment>
              <narrative>Numerator: 1228; Denominator: 1890.</narrative>
            </comment>
          </target>
          <actual value="76.2">
            <comment>
              <narrative>Numerator: 1153; Denominator: 1513.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="65">
            <comment>
              <narrative>Numerator: 2457; Denominator: 3780.</narrative>
            </comment>
          </target>
          <actual value="71.7">
            <comment>
              <narrative>Numerator: 2156; Denominator: 3005.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="66.7">
            <comment>
              <narrative>Numerator: 3802; Denominator: 5702.</narrative>
            </comment>
          </target>
          <actual value="73.8">
            <comment>
              <narrative>Numerator: 3672; Denominator: 4978.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="69.98">
            <comment>
              <narrative>Numerator: 1345; Denominator: 1922.</narrative>
            </comment>
          </target>
          <actual value="76.8">
            <comment>
              <narrative>Numerator: 1516; Denominator: 1973.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 1708.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          <comment>
            <narrative>Numerator: 18; Denominator: 2017; Percentage: 0.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          <comment>
            <narrative>Numerator: 18; Denominator: 2017; Percentage: 0.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          <comment>
            <narrative>Numerator: 18; Denominator: 2017; Percentage: 0.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          <comment>
            <narrative>Numerator: 18; Denominator: 2017; Percentage: 0.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          <comment>
            <narrative>Numerator: 18; Denominator: 2017; Percentage: 0.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          <comment>
            <narrative>Numerator: 18; Denominator: 2017; Percentage: 0.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Others" />
          <comment>
            <narrative>Numerator: 1465; Denominator: 2017; Percentage: 72.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Others" />
          <comment>
            <narrative>Numerator: 1465; Denominator: 2017; Percentage: 72.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Others" />
          <comment>
            <narrative>Numerator: 1465; Denominator: 2017; Percentage: 72.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Others" />
          <comment>
            <narrative>Numerator: 1465; Denominator: 2017; Percentage: 72.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Others" />
          <comment>
            <narrative>Numerator: 1465; Denominator: 2017; Percentage: 72.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Others" />
          <comment>
            <narrative>Numerator: 1465; Denominator: 2017; Percentage: 72.63%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 840.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 830.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
            <comment>
              <narrative>Numerator: 0; Denominator: 1791; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Others" />
            <comment>
              <narrative>Numerator: 830; Denominator: 1791; Percentage: 46.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 955.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 716.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
            <comment>
              <narrative>Numerator: 0; Denominator: 1449; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Others" />
            <comment>
              <narrative>Numerator: 716; Denominator: 1449; Percentage: 49.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 956.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 620.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
            <comment>
              <narrative>Numerator: 2; Denominator: 1253; Percentage: 0.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Others" />
            <comment>
              <narrative>Numerator: 618; Denominator: 1253; Percentage: 49.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 967.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 750.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
            <comment>
              <narrative>Numerator: 4; Denominator: 1494; Percentage: 0.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Others" />
            <comment>
              <narrative>Numerator: 746; Denominator: 1494; Percentage: 49.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 968.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 768.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
            <comment>
              <narrative>Numerator: 8; Denominator: 1500; Percentage: 0.53%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Others" />
            <comment>
              <narrative>Numerator: 760; Denominator: 1500; Percentage: 50.67%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1947.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1791.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 979.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1023.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
            <comment>
              <narrative>Numerator: 4; Denominator: 1973; Percentage: 0.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Others" />
            <comment>
              <narrative>Numerator: 1019; Denominator: 1973; Percentage: 51.65%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="163" />
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="150" />
          <actual value="132" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="163" />
          <actual value="132" />
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="163" />
          <actual value="109" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="173" />
          <actual value="124" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="173" />
          <actual value="126" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="356" />
          <actual value="253" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="183" />
          <actual value="127" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of children &lt;5 in contact with TB patients who began isonizide preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of children &lt;5 in contact with TB patients who began isonizide preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="885" />
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="535" />
          <actual value="389" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="650" />
          <actual value="223" />
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="650" />
          <actual value="276" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="756" />
          <actual value="299" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="1603" />
          <actual value="567" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="756" />
          <actual value="248" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="847" />
          <actual value="319" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 3445.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3097; Denominator: 3445; Percentage: 10.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3097; Denominator: 3445; Percentage: 10.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3097; Denominator: 3445; Percentage: 10.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3097; Denominator: 3445; Percentage: 10.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3097; Denominator: 3445; Percentage: 10.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3097; Denominator: 3445; Percentage: 10.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 348; Denominator: 3445; Percentage: 89.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 348; Denominator: 3445; Percentage: 89.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 348; Denominator: 3445; Percentage: 89.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 348; Denominator: 3445; Percentage: 89.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 348; Denominator: 3445; Percentage: 89.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 348; Denominator: 3445; Percentage: 89.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 2826; Denominator: 3445; Percentage: 81.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 2826; Denominator: 3445; Percentage: 81.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 2826; Denominator: 3445; Percentage: 81.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 2826; Denominator: 3445; Percentage: 81.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 2826; Denominator: 3445; Percentage: 81.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 2826; Denominator: 3445; Percentage: 81.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1492; Denominator: 3445; Percentage: 7.21%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1492; Denominator: 3445; Percentage: 7.21%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1492; Denominator: 3445; Percentage: 7.21%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1492; Denominator: 3445; Percentage: 7.21%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1492; Denominator: 3445; Percentage: 7.21%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1492; Denominator: 3445; Percentage: 7.21%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1953; Denominator: 3445; Percentage: 3.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1953; Denominator: 3445; Percentage: 3.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1953; Denominator: 3445; Percentage: 3.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1953; Denominator: 3445; Percentage: 3.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1953; Denominator: 3445; Percentage: 3.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1953; Denominator: 3445; Percentage: 3.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 3064; Denominator: 3445; Percentage: 43.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 3064; Denominator: 3445; Percentage: 43.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 3064; Denominator: 3445; Percentage: 43.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 3064; Denominator: 3445; Percentage: 43.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 3064; Denominator: 3445; Percentage: 43.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 3064; Denominator: 3445; Percentage: 43.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 130; Denominator: 3445; Percentage: 56.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 130; Denominator: 3445; Percentage: 56.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 130; Denominator: 3445; Percentage: 56.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 130; Denominator: 3445; Percentage: 56.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 130; Denominator: 3445; Percentage: 56.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 130; Denominator: 3445; Percentage: 56.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 251; Denominator: 3445; Percentage: 88.93%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 251; Denominator: 3445; Percentage: 88.93%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 251; Denominator: 3445; Percentage: 88.93%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 251; Denominator: 3445; Percentage: 88.93%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 251; Denominator: 3445; Percentage: 88.93%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 251; Denominator: 3445; Percentage: 88.93%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1784.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1763.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1547; Denominator: 1763; Percentage: 87.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 210; Denominator: 1763; Percentage: 11.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 1428; Denominator: 1763; Percentage: 81%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 690; Denominator: 1763; Percentage: 39.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1073; Denominator: 1763; Percentage: 60.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 1457; Denominator: 1763; Percentage: 82.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 172; Denominator: 1763; Percentage: 9.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 136; Denominator: 1763; Percentage: 7.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1857.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1449.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1306; Denominator: 1449; Percentage: 90.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 133; Denominator: 1449; Percentage: 9.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 1167; Denominator: 1449; Percentage: 80.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 554; Denominator: 1449; Percentage: 38.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 893; Denominator: 1449; Percentage: 61.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 1245; Denominator: 1449; Percentage: 85.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 107; Denominator: 1449; Percentage: 7.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 97; Denominator: 1449; Percentage: 6.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1858.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1253.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1128; Denominator: 1253; Percentage: 90%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 118; Denominator: 1253; Percentage: 9.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 987; Denominator: 1253; Percentage: 78.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 518; Denominator: 1253; Percentage: 41.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 735; Denominator: 1253; Percentage: 58.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 1125; Denominator: 1253; Percentage: 89.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 36; Denominator: 1253; Percentage: 2.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 92; Denominator: 1253; Percentage: 7.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1890.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1494.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1328; Denominator: 1494; Percentage: 88.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 164; Denominator: 1494; Percentage: 11%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 1182; Denominator: 1494; Percentage: 79.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 608; Denominator: 1494; Percentage: 40.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 886; Denominator: 1494; Percentage: 59.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 1370; Denominator: 1494; Percentage: 91.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 22; Denominator: 1494; Percentage: 1.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 102; Denominator: 1494; Percentage: 6.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1890.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1500.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1342; Denominator: 1500; Percentage: 89.47%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 158; Denominator: 1500; Percentage: 10.53%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 1161; Denominator: 1500; Percentage: 77.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 608; Denominator: 1500; Percentage: 40.53%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 892; Denominator: 1500; Percentage: 59.47%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 1317; Denominator: 1500; Percentage: 87.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 35; Denominator: 1500; Percentage: 2.33%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 148; Denominator: 1500; Percentage: 9.87%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3812.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3473.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1922.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1973.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1766; Denominator: 1973; Percentage: 89.51%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 207; Denominator: 1973; Percentage: 10.49%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 1618; Denominator: 1973; Percentage: 82.01%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 801; Denominator: 1973; Percentage: 40.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1172; Denominator: 1973; Percentage: 59.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 1766; Denominator: 1973; Percentage: 89.51%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 33; Denominator: 1973; Percentage: 1.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 174; Denominator: 1973; Percentage: 8.82%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="87.26">
          <comment>
            <narrative>Numerator: 2684; Denominator: 3076.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="95">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2684; Denominator: 3076.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="95">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2684; Denominator: 3076.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="72">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 204; Denominator: 214.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="72">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 204; Denominator: 214.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="87.78">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 2470; Denominator: 2814.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="87.78">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 2470; Denominator: 2814.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="87.78">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 2470; Denominator: 2814.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="71.76">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 122; Denominator: 170.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="71.76">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 122; Denominator: 170.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="71.76">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 122; Denominator: 170.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="88.86">
            <comment>
              <narrative>Numerator: 3110; Denominator: 3500.</narrative>
            </comment>
          </target>
          <actual value="88.4">
            <comment>
              <narrative>Numerator: 2991; Denominator: 3385.</narrative>
            </comment>
          </actual>
          <actual value="87.6">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2621; Denominator: 2993.</narrative>
            </comment>
          </actual>
          <actual value="94.4">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 370; Denominator: 392.</narrative>
            </comment>
          </actual>
          <actual value="0">
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual value="0">
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="89.01">
            <comment>
              <narrative>Numerator: 3175; Denominator: 3567.</narrative>
            </comment>
          </target>
          <actual value="87.6">
            <comment>
              <narrative>Numerator: 3144; Denominator: 3591.</narrative>
            </comment>
          </actual>
          <actual value="89.6">
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 3219; Denominator: 3591.</narrative>
            </comment>
          </actual>
          <actual value="8.9">
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 320; Denominator: 3591.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="89.91">
            <comment>
              <narrative>Numerator: 3340; Denominator: 3715.</narrative>
            </comment>
          </target>
          <actual value="89.2">
            <comment>
              <narrative>Numerator: 2275; Denominator: 2551.</narrative>
            </comment>
          </actual>
          <actual value="93.53">
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 2386; Denominator: 2551.</narrative>
            </comment>
          </actual>
          <actual value="6.19">
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 158; Denominator: 2551.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="76.25">
          <comment>
            <narrative>Numerator: 183; Denominator: 240.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="87.05">
            <comment>
              <narrative>Numerator: 121; Denominator: 139.</narrative>
            </comment>
          </target>
          <actual value="71.6">
            <comment>
              <narrative>Numerator: 96; Denominator: 134.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="90.28">
            <comment>
              <narrative>Numerator: 130; Denominator: 144.</narrative>
            </comment>
          </target>
          <actual value="80.4">
            <comment>
              <narrative>Numerator: 78; Denominator: 97.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="90.28">
            <comment>
              <narrative>Numerator: 260; Denominator: 288.</narrative>
            </comment>
          </target>
          <actual value="97.8">
            <comment>
              <narrative>Numerator: 90; Denominator: 92.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="90.13">
            <comment>
              <narrative>Numerator: 137; Denominator: 152.</narrative>
            </comment>
          </target>
          <actual value="55.8">
            <comment>
              <narrative>Numerator: 58; Denominator: 104.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="90.2">
            <comment>
              <narrative>Numerator: 424; Denominator: 470.</narrative>
            </comment>
          </target>
          <actual value="83">
            <comment>
              <narrative>Numerator: 357; Denominator: 430.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90.13">
            <comment>
              <narrative>Numerator: 274; Denominator: 304.</narrative>
            </comment>
          </target>
          <actual value="82.8">
            <comment>
              <narrative>Numerator: 212; Denominator: 256.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="90.36">
            <comment>
              <narrative>Numerator: 150; Denominator: 166.</narrative>
            </comment>
          </target>
          <actual value="83.3">
            <comment>
              <narrative>Numerator: 145; Denominator: 174.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 973; Denominator: 3501; Percentage: 27.79%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 750; Denominator: 2499; Percentage: 30.01%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 419; Denominator: 2749; Percentage: 15.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 966; Denominator: 2762; Percentage: 34.97%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 118; Denominator: 607; Percentage: 19.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1933; Denominator: 5525; Percentage: 34.99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 273; Denominator: 1624; Percentage: 16.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1215; Denominator: 3038; Percentage: 39.99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 67.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2430; Denominator: 6077; Percentage: 39.99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 628; Denominator: 1971; Percentage: 31.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3934; Denominator: 9419; Percentage: 41.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1022; Denominator: 2998; Percentage: 34.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1504; Denominator: 3342; Percentage: 45%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 394; Denominator: 1027; Percentage: 38.4%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-11T13:38:06+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-GTM-T-MSPAS-3</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Strengthen DOTS Strategy within the Framework of the New Strategy: Stop TB - Guatemala (01-Jul-2022-30-Jun-2025)</narrative>
    </title>
    <description type="1">
      <narrative>Guatemala, Tuberculosis, Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </description>
    <description type="2">
      <narrative>Goal: Reducir la prevalencia, incidencia y mortalidad por tuberculosis en todas sus formas en el país.// Reduce the prevalence, incidence and mortality of all forms of tuberculosis in the country. Objectives: Fortalecer la detección y diagnóstico precoz de la TB y TB-FR, sobretodo en grupos de alto riesgo por medio de uso de pruebas moleculares y otros medios de diagnostico rapidos. //Strengthen the early detection and diagnosis of TB and DR-TB, especially in high-risk groups through the use of molecular tests and other means of rapid diagnosis; Mejorar el éxito de tratamiento de las personas con TB y TB-FR, con el soporte centrado en el paciente. // Improve treatment success for people with TB and DR-TB, with patient-centered support; Disminuir la carga de tuberculosis entre personas que viven con VIH y de VIH en afectados con tuberculosis.// Reduce the burden of tuberculosis among people living with HIV and HIV among those affected with tuberculosis; Mejorar el cumplimiento de las actividades preventivas contra la TB. // Improve compliance of TB prevention activities.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </participating-org>
    <other-identifier ref="GTM-T-MSPASP03" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="3" />
    <activity-date type="1" iso-date="2022-07-01" />
    <activity-date type="2" iso-date="2022-07-01" />
    <activity-date type="3" iso-date="2025-06-30" />
    <activity-date type="4" iso-date="2025-06-30" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Serena Buccini</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>serena.buccini@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="GT" percentage="100">
      <narrative>Guatemala</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="79.28">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="20.72">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="6a7cb452-4c5d-49b6-aa43-8437d24fa1c5" percentage="5.9">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="6.64">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="e61e1ae8-85c6-488f-8a92-215981bf93a2" percentage="2.54">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Social mobilization, building community linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="c9e8bc4a-398e-4c4b-afbb-cf98965f552e" percentage="0.01">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="d110361a-331b-4f72-bd32-016450445cc3" percentage="3.79">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="7d2483ee-e340-40e2-8f81-88b761c385aa" percentage="1.18">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="cc2a3288-298b-4e87-9cd4-3b8c1601d54c" percentage="0.66">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Policy, strategy, governance</narrative>
        </description>
      </budget-item>
      <budget-item code="30f85a5d-1110-4276-932f-a742fc65c90f" percentage="1.78">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="22851d66-f7e4-4cc5-950a-ad9cac3568a2" percentage="4.1">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Community MDR-TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="8194063f-1bf8-4be2-9ebd-2823d5ac44a3" percentage="0.29">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="b108d9bd-d341-43a6-a473-1be4efabc458" percentage="3.15">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Stigma and discrimination reduction (TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a93b0a8f-4b2d-4b43-806e-06b2f2240144" percentage="40.03">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2695e028-456c-4ded-83a4-ded520ff9d79" percentage="0.96">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="e5d69248-af9e-44de-a99d-c2557c675f55" percentage="0.95">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="70cce1e1-1248-426c-b949-2fe2feec2c0a" percentage="0.82">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key Populations (TB care and prevention) - Children</narrative>
        </description>
      </budget-item>
      <budget-item code="a87c4f51-0287-43c7-9064-8f92833da8c6" percentage="0.13">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Mobile populations: refugees, migrants and internally displaced people</narrative>
        </description>
      </budget-item>
      <budget-item code="3d30473b-46e8-4203-ad93-10040d8517cb" percentage="8.19">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="87435fc1-d92b-4039-b203-96061e6e85be" percentage="6.94">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="3ec9daf3-963a-4853-8e5f-65867d3e7630" percentage="8.51">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2b47e4dd-6430-4bc5-829c-127bb93a72a8" percentage="2.66">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2146ce4f-9254-4a2a-8be8-e14734ab53dc" percentage="0.77">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">1889656.23</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">1591901.96</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">739023.52</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">166530.31</value>
    </budget>
    <capital-spend percentage="35.18" />
    <transaction ref="32d50bfe-38ef-480f-aa6d-0b8256a2b22f">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-27" />
      <value currency="USD" value-date="2022-06-27">3431559.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c598524f-8be0-4554-a9e9-f1400214c664">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-01" />
      <value currency="USD" value-date="2022-07-01">366882.52</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b558fc27-fbe5-4b94-8722-8be4d8d8991f">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-07" />
      <value currency="USD" value-date="2022-07-07">57878.40</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4aa70557-6476-47ab-aea1-d5d5862d10b9">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-22" />
      <value currency="USD" value-date="2022-11-22">112506.22</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8f28510a-68f8-4612-9924-59b3d39ccdce">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-22" />
      <value currency="USD" value-date="2022-11-22">6364.29</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="445b9476-12dd-4c6d-898d-07f012bfb1c9">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-16" />
      <value currency="USD" value-date="2023-02-16">57370.81</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="841427a1-e903-4360-b7b9-0fd90c937174">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-16" />
      <value currency="USD" value-date="2023-02-16">904839.64</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ac3db986-8194-42aa-86c4-5f426ecdde2f">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-21" />
      <value currency="USD" value-date="2023-02-21">6175.52</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bb972b79-d59f-4e55-b1ec-bda9ca511b19">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-03-09" />
      <value currency="USD" value-date="2023-03-09">25000.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4d1d45b6-3577-49d0-b158-49e7e60424cd">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-21" />
      <value currency="USD" value-date="2023-03-21">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="eb0f5aff-e675-4ed1-abf8-99bded2f8662">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-06" />
      <value currency="USD" value-date="2023-06-06">4287.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0e91da67-0346-4717-88d8-97377d6ba208">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-07-01" />
      <value currency="USD" value-date="2023-07-01">3812.61</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="86f10fc7-3628-4bbc-a946-67c33e2932dd">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-11" />
      <value currency="USD" value-date="2023-07-11">9325.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9104d8bc-0a3a-49c3-a42b-453bfcf43102">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-12" />
      <value currency="USD" value-date="2023-07-12">-3812.61</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4b8f407e-6bf0-4f00-abdd-5504bd7d3b14">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-18" />
      <value currency="USD" value-date="2023-07-18">51870.98</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="50fa027a-84a2-4fbd-9b55-b943e4121a6f">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-23" />
      <value currency="USD" value-date="2023-07-23">25000.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ad51737c-0426-4b22-b8f6-960bd2ed912d">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-31" />
      <value currency="USD" value-date="2023-08-31">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="063b5c9c-46ed-40c3-9999-f8aeeab8d1c8">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-09-08" />
      <value currency="USD" value-date="2023-09-08">9072.68</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="08ca18d9-32fc-4a54-af6c-7aafc2ad7e81">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-12" />
      <value currency="USD" value-date="2023-09-12">39151.04</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="18aa0e8b-4dbc-4961-aae7-b5497dc8060b">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-12" />
      <value currency="USD" value-date="2023-09-12">7332.82</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c17cb1a6-581f-4fdd-b586-af0eb1cd4674">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-20" />
      <value currency="USD" value-date="2023-09-20">-9072.68</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3c5223e3-17ec-403a-b20a-855268e64737">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-10-05" />
      <value currency="USD" value-date="2023-10-05">90700.48</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="443523fa-dbee-4238-8389-ca6d1246dd19">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-12-04" />
      <value currency="USD" value-date="2023-12-04">1041.30</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4257b6df-2451-4da5-978a-bbad48d03ba6">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-22" />
      <value currency="USD" value-date="2023-12-22">-1041.30</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="beff3039-d1a5-40eb-bcd6-2786dd04b9fd">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-02-26" />
      <value currency="USD" value-date="2024-02-26">1784217.80</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c3c3e0f4-9470-46b1-9c16-63ede3305b12">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-02-26" />
      <value currency="USD" value-date="2024-02-26">-1716874.28</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3ede97f6-1970-48e7-8065-bad050305df8">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-03-01" />
      <value currency="USD" value-date="2024-03-01">635400.80</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c96c62a2-3ab0-419e-8cd3-134fff837815">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-04-12" />
      <value currency="USD" value-date="2024-04-12">11018.38</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d997a2ef-28b8-4ab5-a5d7-0b468ece1b36">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-26" />
      <value currency="USD" value-date="2024-04-26">-11018.38</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5197a40c-8532-4e67-8b30-bec5a9b05600">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-07-01" />
      <value currency="USD" value-date="2024-07-01">3031.41</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c8f9d47e-88c5-4757-8702-e5b641ac0734">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-05" />
      <value currency="USD" value-date="2024-07-05">-3031.41</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ddaaad1e-15b2-404c-85cb-87e2d220f730">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-06" />
      <value currency="USD" value-date="2024-08-06">137698.20</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="be93a829-aca6-4aae-a713-d43a694b49a2">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-20" />
      <value currency="USD" value-date="2024-08-20">89632.66</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c0e547a4-6987-4b1a-9b33-53bcf288aa6c">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-09-01" />
      <value currency="USD" value-date="2024-09-01">4154.74</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ce57fb6d-f533-4a03-a3f1-944f73dc1333">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-09-10" />
      <value currency="USD" value-date="2024-09-10">24619.97</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e580805a-2076-42f2-95f9-21c059a72c08">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-09-10" />
      <value currency="USD" value-date="2024-09-10">490260.52</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="191e5eff-46af-4333-8858-cee5e3a8523b">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-30" />
      <value currency="USD" value-date="2024-09-30">-4154.74</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6cff2a94-9fba-4764-b6a7-157d9699fe47">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-30" />
      <value currency="USD" value-date="2024-09-30">-6615.04</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3bff1c2d-e120-4d27-8191-7c9ad498b8c4">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-10-01" />
      <value currency="USD" value-date="2024-10-01">6615.04</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="df395c4c-5d83-40a5-90dd-548e7d358d56">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-19" />
      <value currency="USD" value-date="2024-11-19">202398.36</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0a8d88c3-6c01-4091-b526-c8389a021928">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-02-04" />
      <value currency="USD" value-date="2025-02-04">769963.24</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="27aab0f5-5133-4619-960c-46ec1691b6cf">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-02-04" />
      <value currency="USD" value-date="2025-02-04">-204207.29</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="73ed9294-04dc-4b12-817d-07e3232ba8b3">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-02-27" />
      <value currency="USD" value-date="2025-02-27">532121.87</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="03029b9c-e38f-4e13-bb31-f4e85539ef81">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-03-07" />
      <value currency="USD" value-date="2025-03-07">103.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="87975067-a823-41ea-bd83-737168ab95bc">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-26" />
      <value currency="USD" value-date="2025-03-26">-103.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="729394d2-9906-4764-a144-28981c9822fc">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-08" />
      <value currency="USD" value-date="2025-05-08">204451.37</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7860197b-8454-4ed2-bac3-77b085128f4c">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-08" />
      <value currency="USD" value-date="2025-05-08">-237841.37</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e2eeebd3-f275-4ba7-aba8-15a3251a240f">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-05-13" />
      <value currency="USD" value-date="2025-05-13">55394.28</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ca66782c-8fcf-43a5-99d6-c03fc5bd5471">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-06-05" />
      <value currency="USD" value-date="2025-06-05">5663.99</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="39bc5a57-555f-4c31-9c0c-0a1724d93cc0">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-11" />
      <value currency="USD" value-date="2025-06-11">15100.86</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7ef4f791-a2c0-494d-86dc-916b57edd8b6">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-13" />
      <value currency="USD" value-date="2025-06-13">-5663.99</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8cec00a9-ba67-48c7-bc52-0fc0bc8c7cce">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-09-01" />
      <value currency="USD" value-date="2025-09-01">1553.02</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b97511f9-6d54-4cab-9038-9f5ddb6542b6">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-09-15" />
      <value currency="USD" value-date="2025-09-15">-1553.02</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8851a830-385c-4ce1-a491-13600bebea7c">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-03-09" />
      <value currency="USD" value-date="2026-03-09">1294.44</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e7b9de10-67b9-413a-b69c-e4bca2fa67fc">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-17" />
      <value currency="USD" value-date="2026-03-17">-1294.44</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4c83803c-9699-4f3f-84d8-8d145d541b2c">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-28" />
      <value currency="USD" value-date="2026-05-28">-133956.23</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="93fdbb2b-1b94-4208-88ac-9d0413c6497e">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-10-09" />
      <value currency="USD" value-date="2026-10-09">225054.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="307eab11-804c-40d6-b8f3-8a1f091accc2">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-09" />
      <value currency="USD" value-date="2026-10-09">-225054.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="GTM-T-MSPASP03-EXP-20230630">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-06-30" />
      <value currency="USD" value-date="2023-06-30">899600.51</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health and Social Assistance of the Republic of Guatemala for GTM-T-MSPASP03, Jul 2022 to Jun 2023.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
    </transaction>
    <transaction ref="GTM-T-MSPASP03-EXP-20240630">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-06-30" />
      <value currency="USD" value-date="2024-06-30">927421.08</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health and Social Assistance of the Republic of Guatemala for GTM-T-MSPASP03, Jul 2023 to Jun 2024.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
    </transaction>
    <transaction ref="GTM-T-MSPASP03-EXP-20250630">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">1957002.00</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health and Social Assistance of the Republic of Guatemala for GTM-T-MSPASP03, Jul 2024 to Jun 2025.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
    </transaction>
    <transaction ref="GTM-T-MSPASP03-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">2983.04</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health and Social Assistance of the Republic of Guatemala for GTM-T-MSPASP03, Jul 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/GTM-T-MSPAS" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/GTM/2021/Tuberculosis/en/GTM-T_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2021 - Funding Request - Window 6 - Tuberculosis - Guatemala - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1045-GTM-T.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2021-09-10" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/GTM/2021/Tuberculosis/es/GTM-T_FundingRequest_1_es.zip" format="application/zip">
      <title>
        <narrative>2021 - Funding Request - Window 6 - Tuberculosis - Guatemala - Español</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1045-GTM-T.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="es" />
      <document-date iso-date="2021-09-10" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 103.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1; Denominator: 103; Percentage: 0.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1; Denominator: 103; Percentage: 0.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 102; Denominator: 103; Percentage: 99.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 102; Denominator: 103; Percentage: 99.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 65; Denominator: 103; Percentage: 63.11%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 65; Denominator: 103; Percentage: 63.11%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 38; Denominator: 103; Percentage: 36.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 38; Denominator: 103; Percentage: 36.89%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 54.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 27.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 27; Denominator: 27; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 27; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 11; Denominator: 27; Percentage: 40.74%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 16; Denominator: 27; Percentage: 59.26%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 111.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 67.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 57.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 40.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 56.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 30.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 115.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 64.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 59.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 34.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 59.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 120.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 76.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 61.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 34.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 32.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 2.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 9.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 25.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 86.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1; Denominator: 86; Percentage: 1.16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1; Denominator: 86; Percentage: 1.16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 85; Denominator: 86; Percentage: 98.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 85; Denominator: 86; Percentage: 98.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 0; Denominator: 86; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 0; Denominator: 86; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 77; Denominator: 86; Percentage: 89.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 77; Denominator: 86; Percentage: 89.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 34; Denominator: 86; Percentage: 39.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 34; Denominator: 86; Percentage: 39.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 51; Denominator: 86; Percentage: 59.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 51; Denominator: 86; Percentage: 59.3%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 49.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 24.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 24; Denominator: 24; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 24; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 9; Denominator: 24; Percentage: 37.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 15; Denominator: 24; Percentage: 62.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 24; Denominator: 24; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 24; Denominator: 24; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 99.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 52.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 50.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 28.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 108.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 57.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 53.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 26.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 55.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 31.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 57.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 115.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 70.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 58.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 31.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 29.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 2.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 22.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 22.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 31.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 17.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="243" />
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="279" />
          <actual value="293" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="134" />
          <actual value="162" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="145" />
          <actual value="131" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="303" />
          <actual value="329" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="146" />
          <actual value="184" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="157" />
          <actual value="145" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="158" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="327" />
          <actual value="367" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="169" />
          <actual value="181" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 3762.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 442; Denominator: 3762; Percentage: 11.75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 442; Denominator: 3762; Percentage: 11.75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 3256; Denominator: 3762; Percentage: 86.55%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 3256; Denominator: 3762; Percentage: 86.55%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 2248; Denominator: 3762; Percentage: 59.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 2248; Denominator: 3762; Percentage: 59.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 224; Denominator: 3762; Percentage: 5.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 224; Denominator: 3762; Percentage: 5.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2985; Denominator: 3762; Percentage: 79.35%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2985; Denominator: 3762; Percentage: 79.35%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 401; Denominator: 3762; Percentage: 10.66%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 401; Denominator: 3762; Percentage: 10.66%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 1514; Denominator: 3762; Percentage: 40.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 1514; Denominator: 3762; Percentage: 40.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 3137; Denominator: 3762; Percentage: 83.39%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 3137; Denominator: 3762; Percentage: 83.39%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1942.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2055.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1825; Denominator: 2055; Percentage: 88.81%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 218; Denominator: 2055; Percentage: 10.61%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 1715; Denominator: 2055; Percentage: 83.45%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 846; Denominator: 2055; Percentage: 41.17%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1209; Denominator: 2055; Percentage: 58.83%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 1860; Denominator: 2055; Percentage: 90.51%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 48; Denominator: 2055; Percentage: 2.34%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 147; Denominator: 2055; Percentage: 7.15%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3945.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4350.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2003.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2295.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2003.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2275.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4073.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4620.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2070.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2345.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4209.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4508.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2071.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2138.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2297.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2141.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 156.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 1952.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 975.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1322.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 2065.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 46.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 186.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 1078.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 13; Denominator: 1078; Percentage: 1.21%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 13; Denominator: 1078; Percentage: 1.21%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 145; Denominator: 1078; Percentage: 13.45%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 145; Denominator: 1078; Percentage: 13.45%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 908; Denominator: 1078; Percentage: 84.23%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 908; Denominator: 1078; Percentage: 84.23%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 990.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1057.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 127; Denominator: 1057; Percentage: 12.02%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 541; Denominator: 1057; Percentage: 51.18%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 375; Denominator: 1057; Percentage: 35.48%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2352.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2134.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1362.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1077.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3121.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1911.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1362.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 834.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1759.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1077.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1760.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3941.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2631.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2181.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1492.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 355.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 514.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 392.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="84.58">
          <comment>
            <narrative>Numerator: 3144; Denominator: 3717.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="86.6">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 3219; Denominator: 3717.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="1.4">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 52; Denominator: 3717.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="34.49">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 1282; Denominator: 3717.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="72.82">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 2309; Denominator: 3171.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="8.61">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 320; Denominator: 3717.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="88">
            <comment>
              <narrative>Numerator: 3418; Denominator: 3884.</narrative>
            </comment>
          </target>
          <actual value="86.2">
            <comment>
              <narrative>Numerator: 2532; Denominator: 2937.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="88">
            <comment>
              <narrative>Numerator: 3418; Denominator: 3884.</narrative>
            </comment>
          </target>
          <actual value="86.2">
            <comment>
              <narrative>Numerator: 2532; Denominator: 2937.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 3605; Denominator: 4006.</narrative>
            </comment>
          </target>
          <actual value="86.9">
            <comment>
              <narrative>Numerator: 3502; Denominator: 4032.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="89.99">
            <comment>
              <narrative>Numerator: 3605; Denominator: 4006.</narrative>
            </comment>
          </target>
          <actual value="86.9">
            <comment>
              <narrative>Numerator: 3502; Denominator: 4032.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 3726; Denominator: 4141.</narrative>
            </comment>
          </target>
          <actual value="84.72">
            <comment>
              <narrative>Numerator: 3858; Denominator: 4554.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="89.98">
            <comment>
              <narrative>Numerator: 3726; Denominator: 4141.</narrative>
            </comment>
          </target>
          <actual value="84.72">
            <comment>
              <narrative>Numerator: 3858; Denominator: 4554.</narrative>
            </comment>
          </actual>
          <actual value="40.01">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1822; Denominator: 4554.</narrative>
            </comment>
          </actual>
          <actual value="59.99">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2732; Denominator: 4554.</narrative>
            </comment>
          </actual>
          <actual value="90.01">
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 4099; Denominator: 4554.</narrative>
            </comment>
          </actual>
          <actual value="2">
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 91; Denominator: 4554.</narrative>
            </comment>
          </actual>
          <actual value="7.99">
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 364; Denominator: 4554.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="85.85">
          <comment>
            <narrative>Numerator: 358; Denominator: 417.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="87.27">
            <comment>
              <narrative>Numerator: 192; Denominator: 220.</narrative>
            </comment>
          </target>
          <actual value="77.6">
            <comment>
              <narrative>Numerator: 114; Denominator: 147.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="88.9">
            <comment>
              <narrative>Numerator: 400; Denominator: 450.</narrative>
            </comment>
          </target>
          <actual value="88.3">
            <comment>
              <narrative>Numerator: 272; Denominator: 308.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90.43">
            <comment>
              <narrative>Numerator: 208; Denominator: 230.</narrative>
            </comment>
          </target>
          <actual value="98.1">
            <comment>
              <narrative>Numerator: 158; Denominator: 161.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="91.9">
            <comment>
              <narrative>Numerator: 432; Denominator: 470.</narrative>
            </comment>
          </target>
          <actual value="77.4">
            <comment>
              <narrative>Numerator: 312; Denominator: 403.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90.87">
            <comment>
              <narrative>Numerator: 209; Denominator: 230.</narrative>
            </comment>
          </target>
          <actual value="82.7">
            <comment>
              <narrative>Numerator: 158; Denominator: 191.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="92.92">
            <comment>
              <narrative>Numerator: 223; Denominator: 240.</narrative>
            </comment>
          </target>
          <actual value="72.6">
            <comment>
              <narrative>Numerator: 154; Denominator: 212.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="92.92">
            <comment>
              <narrative>Numerator: 223; Denominator: 240.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="93.5">
            <comment>
              <narrative>Numerator: 460; Denominator: 492.</narrative>
            </comment>
          </target>
          <actual value="72.89">
            <comment>
              <narrative>Numerator: 277; Denominator: 380.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="94.05">
            <comment>
              <narrative>Numerator: 237; Denominator: 252.</narrative>
            </comment>
          </target>
          <actual value="80.11">
            <comment>
              <narrative>Numerator: 149; Denominator: 186.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-11T13:38:06+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-GTM-T-MSPAS-4</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>To reduce tuberculosis prevalence, incidence, and mortality by strengthening integrated care of promotion, prevention and cure services, with a focus on the person, family and community; with support of multisectors and civil society - Guatemala (01-Jul-2025-30-Jun-2028)</narrative>
    </title>
    <description type="1">
      <narrative>Guatemala, Tuberculosis, Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </description>
    <description type="2">
      <narrative>Goal: Reducir la prevalencia, incidencia, mortalidad y el sufrimiento humano por tuberculosis en el país, fortaleciendo la atención integrada de servicios de promoción, prevención y curación, con enfoque centrado en la persona, la familia y la comunidad;  contando con el apoyo e involucramiento multisectorial y de la sociedad civil. / Reduce the prevalence, incidence, mortality and human suffering due to tuberculosis in the country, strengthening integrated care of promotion, prevention and cure services, with a focus on the person, family and community; with the support and involvement of multisectors and civil society. Objectives: Fortalecer la prevención y atención integrada e integral de la tuberculosis centrada en la persona, familia, comunidad y su entorno, principalmente en grupos de alto riesgo. / Strengthen integrated and comprehensive prevention and care of tuberculosis focused on the person, family, community and their environment, mainly in high-risk groups; Fortalecer el compromiso de las comunidades, las organizaciones de la sociedad civil y todos los proveedores de atención públicos y privados para el control de la TB / Strengthen the commitment of communities, civil society organizations and all public and private care providers for TB control; Mejorar la calidad y oportunidad del sistema de información y notificación de casos de TB y mortalidad por TB, / Improve the quality and timeliness of the information and notification system for TB cases and TB mortality,.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </participating-org>
    <other-identifier ref="GTM-T-MSPASP04" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2025-07-01" />
    <activity-date type="2" iso-date="2025-07-01" />
    <activity-date type="3" iso-date="2028-06-30" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Serena Buccini</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>serena.buccini@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="GT" percentage="100">
      <narrative>Guatemala</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="62.74">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="37.26">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="cd09d6c8-13e6-412e-a54d-84c32d99a370" percentage="1.56">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="10.13">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="09d00f5e-f29a-445c-a7e5-4a1e21a3dce7" percentage="2.68">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Laboratory-based surveillance</narrative>
        </description>
      </budget-item>
      <budget-item code="19ae85a9-12db-4fb8-9313-84f9feef29a0" percentage="3.52">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: National laboratory governance and management structures</narrative>
        </description>
      </budget-item>
      <budget-item code="db62704e-5b08-4eb1-b5cb-39a697705c19" percentage="2.83">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Capacity building and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="7dbf6454-4357-4937-89a1-9a1c7f0174fa" percentage="4.32">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community engagement, linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="31d3a0e8-e9f1-4c88-b1b7-ce75b4e952eb" percentage="1.52">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity, design &amp; operations</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="2.73">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="6.71">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="1a5ab4c7-9695-4567-adb4-0a3768fa01ee" percentage="1.27">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="fd4720c3-77e8-4b8a-8c90-69c1ae68c5e7" percentage="0.97">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Collaboration with other programs/sectors</narrative>
        </description>
      </budget-item>
      <budget-item code="ea39b4f6-cd94-4310-b181-394f794f9144" percentage="3.83">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="4.81">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="99700b2a-3a9a-4855-b789-986d7a150e52" percentage="0.6">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Children and adolescents</narrative>
        </description>
      </budget-item>
      <budget-item code="1ed5e501-534e-43ae-bb9f-9552bd6bf461" percentage="0.19">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Mobile population (migrants/refugees/IDPs)</narrative>
        </description>
      </budget-item>
      <budget-item code="03989069-d574-46fc-9fad-200e03cde744" percentage="18.48">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="99e62de4-459a-4fc3-a5da-f5297d23736d" percentage="2.77">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - People in prisons/jails/detention centers</narrative>
        </description>
      </budget-item>
      <budget-item code="23608000-3108-4c67-92d0-b1a31eb68b3f" percentage="5.24">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Eliminating TB-related stigma and discrimination</narrative>
        </description>
      </budget-item>
      <budget-item code="f50f08b4-b9d9-4b4a-a8b2-065858f9ce31" percentage="23.15">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="7332ed72-b538-4ab5-b90e-f820e56c0c5b" percentage="1.31">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Infection prevention and control (IPC)</narrative>
        </description>
      </budget-item>
      <budget-item code="68262ac7-05ab-4aec-9c9e-320d5883c55c" percentage="0.49">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Screening/testing for TB infection</narrative>
        </description>
      </budget-item>
      <budget-item code="8f363382-1b81-4d2d-a396-2be1435016f2" percentage="0.12">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="7c7a7505-bdfe-4146-976c-78a03ca0d545" percentage="0.77">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">1389690.78</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">1266717.05</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2027-01-01" />
      <period-end iso-date="2027-12-31" />
      <value currency="USD" value-date="2027-01-01">494224.26</value>
    </budget>
    <capital-spend percentage="24.12" />
    <transaction ref="69b2f6f4-c494-498b-bd3e-c139a3e81b9c">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-09-29" />
      <value currency="USD" value-date="2025-09-29">1301443.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f4e2b07a-46bb-4203-9671-e44790b3ce63">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-01" />
      <value currency="USD" value-date="2025-10-01">677993.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="04ec60e5-7836-4d8a-8ba7-95addce9037a">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-14" />
      <value currency="USD" value-date="2026-04-14">67352.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e152f6f8-82c0-4301-9c56-48f0731afb29">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">36149.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="e6294659-9c2f-4b73-adef-f825f2f35b3b">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">31203.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="cb526fdf-23c5-43d5-a818-29288944ca85">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-14" />
      <value currency="USD" value-date="2026-07-14">16197.36</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e00e7d41-6099-4c06-b812-d87797210ce2">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-14" />
      <value currency="USD" value-date="2026-07-14">93247.23</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e8dc49ee-b3ee-4fc8-ac70-e12385b749bb">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-21" />
      <value currency="USD" value-date="2026-07-21">30114.20</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="875b2ec8-3acc-423c-afe6-a7e450234854">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-08" />
      <value currency="USD" value-date="2026-09-08">174878.46</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b4fb25db-29c6-4f57-a3a1-e501042e0efb">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-08" />
      <value currency="USD" value-date="2026-09-08">4564.83</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="250e68bf-ef87-4ac0-9333-02c1184701b5">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-09" />
      <value currency="USD" value-date="2026-10-09">225054.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5c7c8a0d-cd79-4cdf-baad-707e5261d651">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-09" />
      <value currency="USD" value-date="2026-10-09">225054.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="GTM-T-MSPASP04-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">81558.13</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health and Social Assistance of the Republic of Guatemala for GTM-T-MSPASP04, Jul 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/GTM-T-MSPAS" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/GTM/2024/Tuberculosis/en/GTM-T_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2024 - Funding Request - Window 6 - Tuberculosis - Guatemala - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1666-GTM-T.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2024-09-09" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/GTM/2024/Tuberculosis/es/GTM-T_FundingRequest_1_es.zip" format="application/zip">
      <title>
        <narrative>2024 - Funding Request - Window 6 - Tuberculosis - Guatemala - Español</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1666-GTM-T.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="es" />
      <document-date iso-date="2024-09-09" />
    </document-link>
    <conditions attached="1">
      <condition type="1">
        <narrative>1 - Personal Data (1) Principles. The Principal Recipient, acknowledges that Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with applicable law and/or policy; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons.</narrative>
      </condition>
      <condition type="1">
        <narrative>2 - With respect to Section 7.6 (Right of Access) of the Global Fund Grant Regulations (as amended from time to time), (1) the Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data, and (2), prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any applicable law or regulation.</narrative>
      </condition>
      <condition type="1">
        <narrative>3 - (1) In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of USD 472,595 based on a 15% of the Tuberculosis component communicated in the Allocation Letter (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction of the Grantee’s compliance with the requirements listed at 6.3(1)(a) and 6.3(1)(b) below (“Co-Financing Requirements”). The Principal Recipient acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Grantee fails to: (a) maintain government expenditure on health to meet national universal health coverage goals; and/or (b) maintain domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Grantee shall, as set out in Oficio Despacho Superior-JDCH/VRVCS-ERGB-0068-2025 Ref. 1303-2025, dated 15 April 2025 (the “Commitment Letter”), unless otherwise agreed in writing by the Global Fund: (a) fulfil a total minimum co-financing commitment of USD 17,300,556 from 2025-2028 (inclusive), comprising investments in Tuberculosis. This amount will be included in the institutional budget of the Grantee, and the multi-annual budget for the subsequent years; and (b) fulfil the programmatic commitments as stipulated in the Commitment Letter; and (c) provide to the Global Fund, by no later than 30 of April of each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including: i. the approved annual budget for Tuberculosis for the upcoming year; ii. the total expenditure for Tuberculosis in the previous fiscal year; and iii. evidence of specific programmatic commitments as ser out in the Commitment Letter.</narrative>
      </condition>
      <condition type="2">
        <narrative>5 - The Program budget may be funded in part by Grant Funds disbursed under a previous Grant Agreement, which the Global Fund has approved to be used for the Program under the current Grant Agreement (“Previously Disbursed Grant Funds”), as well as additional Grant Funds up to the amount set forth in Section 3.6. hereof. Accordingly, the Global Fund may reduce the amount of Grant Funds set forth in Section 3.6. hereof by the amount of any Previously Disbursed Grant Funds. Previously Disbursed Grant Funds shall be governed by the terms of this Grant Agreement.</narrative>
      </condition>
    </conditions>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 73.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 66; Denominator: 76; Percentage: 86.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 10; Denominator: 76; Percentage: 13.16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 33; Denominator: 76; Percentage: 43.42%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 41; Denominator: 76; Percentage: 53.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 63; Denominator: 76; Percentage: 82.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 7; Denominator: 76; Percentage: 9.21%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 7; Denominator: 76; Percentage: 9.21%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 48.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 45.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 48.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 28.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 25.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 3.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 12.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 16.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 26.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 2.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 99.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-07-01" />
          <period-end iso-date="2028-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 106.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 62; Denominator: 73; Percentage: 84.93%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 54; Denominator: 64; Percentage: 84.38%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 10; Denominator: 64; Percentage: 15.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 29; Denominator: 64; Percentage: 45.31%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 2; Denominator: 64; Percentage: 3.13%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 35; Denominator: 64; Percentage: 54.69%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 58; Denominator: 64; Percentage: 90.63%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 87.5%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 86.67%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 87.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 26; Denominator: 28; Percentage: 92.86%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 23; Denominator: 26; Percentage: 88.46%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 3; Denominator: 26; Percentage: 11.54%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 15; Denominator: 26; Percentage: 57.69%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 1.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 11; Denominator: 26; Percentage: 42.31%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 25.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 90.2%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-07-01" />
          <period-end iso-date="2028-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 90.74%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 65; Denominator: 66; Percentage: 98.48%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1; Denominator: 66; Percentage: 1.52%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 25; Denominator: 66; Percentage: 37.88%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 3; Denominator: 66; Percentage: 4.55%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 41; Denominator: 66; Percentage: 62.12%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 58; Denominator: 66; Percentage: 87.88%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 7; Denominator: 66; Percentage: 10.61%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Private" />
          <comment>
            <narrative>Numerator: 0; Denominator: 66; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 66; Denominator: 66; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 62; Denominator: 66; Percentage: 93.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 1; Denominator: 66; Percentage: 1.52%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 46; Denominator: 66; Percentage: 69.7%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 75%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 75%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 46; Denominator: 68; Percentage: 67.65%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 43; Denominator: 65; Percentage: 66.15%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 3; Denominator: 3; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 18; Denominator: 68; Percentage: 26.47%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 16.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 28; Denominator: 68; Percentage: 41.18%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 44; Denominator: 68; Percentage: 64.71%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 2; Denominator: 68; Percentage: 2.94%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Private" />
            <comment>
              <narrative>Numerator: 0; Denominator: 68; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 68; Denominator: 68; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 30.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 0; Denominator: 68; Percentage: 0%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 80%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-07-01" />
          <period-end iso-date="2028-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 85%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with TB (all forms) notified among key affected populations/high risk groups (other than prisoners); *includes only those with new and relapse</narrative>
      </title>
      <description>
        <narrative>Module: Key and vulnerable populations (KVP) - TB/DR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with TB (all forms) notified among key affected populations/high risk groups (other than prisoners); *includes only those with new and relapse</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="1875" />
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="965.5" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="985" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="985" />
          <actual value="1297" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="1921" />
        </period>
        <period>
          <period-start iso-date="2027-07-01" />
          <period-end iso-date="2028-06-30" />
          <target value="1830" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes</narrative>
      </title>
      <description>
        <narrative>Module: RSSH/PP: Laboratory systems (including national and peripheral).</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="95.45">
          <comment>
            <narrative>Numerator: 21; Denominator: 22.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="96">
            <comment>
              <narrative>Numerator: 24; Denominator: 25.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="96.88">
            <comment>
              <narrative>Numerator: 31; Denominator: 32.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-07-01" />
          <period-end iso-date="2028-06-30" />
          <target value="97.14">
            <comment>
              <narrative>Numerator: 34; Denominator: 35.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of community organizations that received a pre-defined package of training</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Community systems strengthening.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of community organizations that received a pre-defined package of training</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="4" />
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="12" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="20" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="20" />
          <actual value="35" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="64" />
        </period>
        <period>
          <period-start iso-date="2027-07-01" />
          <period-end iso-date="2028-06-30" />
          <target value="99" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of reporting units which digitally enter and submit data at the reporting unit level using the electronic information system</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Monitoring and evaluation systems.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of reporting units which digitally enter and submit data at the reporting unit level using the electronic information system</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="0">
          <comment>
            <narrative>Numerator: 0; Denominator: 29.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="13.79">
            <comment>
              <narrative>Numerator: 4; Denominator: 29.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="13.8">
            <comment>
              <narrative>Numerator: 4; Denominator: 29.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="13.79">
            <comment>
              <narrative>Numerator: 4; Denominator: 29.</narrative>
            </comment>
          </target>
          <actual value="0">
            <comment>
              <narrative>Numerator: 0; Denominator: 29.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="41.38">
            <comment>
              <narrative>Numerator: 12; Denominator: 29.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-07-01" />
          <period-end iso-date="2028-06-30" />
          <target value="68.97">
            <comment>
              <narrative>Numerator: 20; Denominator: 29.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 4617.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3940; Denominator: 4617; Percentage: 85.34%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 677; Denominator: 4617; Percentage: 14.66%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 3758; Denominator: 4617; Percentage: 81.39%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1818; Denominator: 4617; Percentage: 39.38%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2799; Denominator: 4617; Percentage: 60.62%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 4157; Denominator: 4617; Percentage: 90.04%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 353; Denominator: 4617; Percentage: 7.65%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 107; Denominator: 4617; Percentage: 2.32%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2471.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2423.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2471.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2563.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2406.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 157.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 2200.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 950.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1613.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 2308.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 211.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 44.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4943.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-07-01" />
          <period-end iso-date="2028-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4703.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 3073; Denominator: 4617; Percentage: 66.56%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Provider type" value="Private" />
          <comment>
            <narrative>Numerator: 3063; Denominator: 3073; Percentage: 99.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 10; Denominator: 3073; Percentage: 0.33%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 71%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 71%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 71%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1671; Denominator: 2563; Percentage: 65.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Private" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 1671.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 84.2%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-07-01" />
          <period-end iso-date="2028-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 85.01%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="86.86">
          <comment>
            <narrative>Numerator: 3502; Denominator: 4032.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="85.54">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3449; Denominator: 4032.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="14.46">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 583; Denominator: 4032.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="40.28">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1624; Denominator: 4032.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="59.72">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2408; Denominator: 4032.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="88.59">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 3572; Denominator: 4032.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="7.59">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 306; Denominator: 4032.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="3.82">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 154; Denominator: 4032.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="88" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="88" />
          <actual value="84.47">
            <comment>
              <narrative>Numerator: 2758; Denominator: 3265.</narrative>
            </comment>
          </actual>
          <actual value="82.77">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2388; Denominator: 2885.</narrative>
            </comment>
          </actual>
          <actual value="97.37">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 370; Denominator: 380.</narrative>
            </comment>
          </actual>
          <actual value="33.14">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1082; Denominator: 3265.</narrative>
            </comment>
          </actual>
          <actual value="51.33">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1676; Denominator: 3265.</narrative>
            </comment>
          </actual>
          <actual value="0">
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 0; Denominator: 3265.</narrative>
            </comment>
          </actual>
          <actual value="8.24">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 269; Denominator: 3265.</narrative>
            </comment>
          </actual>
          <actual value="0">
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 0; Denominator: 3265.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="90" />
        </period>
        <period>
          <period-start iso-date="2027-07-01" />
          <period-end iso-date="2028-06-30" />
          <target value="90" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="883" />
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="550" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="747" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="747" />
          <actual value="2009" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="1635" />
        </period>
        <period>
          <period-start iso-date="2027-07-01" />
          <period-end iso-date="2028-06-30" />
          <target value="1899" />
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>